XKEM won lawsuit against Giant Drug manufacture Brystol Myers.
XKEM,has a knockoff cancer drug coming to market soon, also has a Sickel Cell drug out this quarter.Just won a law suit against Brystol Myers, which in itself is impressive for a penny stock company to win against one of the giant drug manufacturers. This stock should have news out this week or next week regarding the Sickell Cell drug coming to market. I like the potential of XKEM.
Posted by: dawg245 In reply to: thewallmaster who wrote msg# 319 Date:2/24/2006 5:12:35 PM Post #of 331
What impresses me is that XKEM went head to head with Bristol-Myers........and won. Now, if the sickle cell drug expands from Nigeria to the rest of the world we will all be rich, very rich.
TAKE THAT NAKED SHORTERS -----------------------------------------------
XKEM buy alert The SouthEnd Stock Pickers helps investors win at investing on the merits of radically original thinking and an unbeatable track record of picking stocks with huge potential. We're here for you with commonsense, the big ideas, and a little inspiration to turn your portfolio into a monster performer. We've brought you GTE, GOOG, SIRI, CMGI, JDSU,HISC, and others you've made a killing on! If it doesn't make commonsense, it makes nosense to us or you.
At SouthEnd Stock Pickers, we're focusing solely on undervalued Nasdaq stocks that we feel will return potential profits of 500%+ in 1 to 3 weeks. Our New picks have hours and hours of research listed below.Our SouthEnd Team uses a new breakthrough method of hardcore stock picks.$$ WE ARE HERE TO MAKE YOU MONEY $$
Our new pick for 22/FEB/2006 is =(XKEM) was picked up of (INSIDER BUYING)
Accumulation........is the key word
Xechem International,Inc,
Ticker Symbol = XKEM
Market Cap = $ 1. 90M
Industry: Biotechnology
Target Price = $ 0.24
Recommendation: SUPER MEGA BUY
There are many reasons to buy into (XKEM) $DO YOUR DD A HUGE WINNER HERE $
Once News on the Approval of the NIGERIA plant comes out SKY HIGH SHE GOES .
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.